Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Intravenous Ascorbic Acid in Treatment of Metastatic Hepatocellular Carcinoma

NCT01754987 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT01754987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01754987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Intravenous Ascorbic Acid in Treatment of Metastatic Hepatocellular Carcinoma
Lead sponsor
Thomas Jefferson University
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2012
Completion date
January 31, 2016
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced liver cancer, metastatic hepatocellular carcinoma